Racing Medication Testing Consortium

What Racing Medication Testing Consortium does

The Racing Medication and Testing Consortium (RMTC) is a Lexington, Kentucky-based non-profit corporation established in 2003 that funds scientific research, develops science-based medication regulation recommendations, and delivers continuing education for the North American horse racing industry. Its 23-member coalition spans owners, breeders, trainers, veterinarians, jockeys, regulators, racetracks, racing associations, and breed organizations, including AAEP, AQHA, The Jockey Club, NTRA, NYRA, Churchill Downs, Keeneland, the Stronach Group, and Breeders' Cup. RMTC's flagship output is the Schedule of Controlled Therapeutic Substances (CTS), which since 2013 has set regulatory thresholds and withdrawal guidance for 28 therapeutic medications; its recommendations are adopted through ARCI Model Rules by state racing commissions across the continent.

RMTC has invested more than $3 million in over 50 studies at Cornell, UC Davis, University of Pennsylvania, University of Florida, Ohio State, and Colorado State, producing 40+ peer-reviewed publications on pharmacokinetics, pharmacodynamics, doping threats, and testing methods. The underlying analytical technology includes Gas Chromatography/Mass Spectrometry and Liquid Chromatography/Mass Spectrometry for drug detection, paired with the FDA-aligned 95/95 Tolerance Interval statistical methodology for deriving population-scale thresholds. The Horseracing Testing Laboratory Committee operates the External Quality Assurance Program (EQAP), which accredits equine drug testing laboratories. Since 2018, the RegVet CE annual conference has trained 160+ regulatory veterinarians from the U.S., U.K., Australia, Hong Kong, Chile, and Uruguay, and in 2024 the consortium launched the Racing Industry Veterinary Student Externship Program.

RMTC is funded primarily by member organization contributions supplemented by Integrity Partner donations (William M. Backer Foundation, Perry R. Bass II Foundation, Paul & Kathryn Smoke, and Adele Dilschneider). Core research, advisories, bulletins, and best practices are distributed free of charge; revenue from the RegVet CE program is generated via registration fees of $225 for the webinar series, $450 for the in-person event, and $525 for a combined package. RMTC also operates as a strategic advisor to HISA and HIWU on anti-doping and medication control, and integrates its content into the University of Arizona Racetrack Industries Program, Godolphin Flying Start, and ROAP schools.

Name

Racing Medication Testing Consortium

Legal name

Racing Medication and Testing Consortium

Website

https://rmtcnet.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

RMTC is a Lexington-based non-profit consortium of 23 horse racing industry organizations that funds pharmacokinetic research, sets regulatory thresholds for 28 controlled therapeutic medications, accredits drug testing laboratories, and trains regulatory veterinarians via its RegVet CE program.

Ownership category

akta.pro rank

Product category

Equine Medication Regulation Services

NAICS

Veterinary Services (54194), Scientific Research and Development Services (5417), Testing Laboratories and Services (54138)

SIC

Services-Racing, Including Track Operation (7948), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Racing Associations, Governance & Integrity Services (MPAEADAL)

akta.pro secondary industries

Equine Veterinary, Welfare & Anti-Doping Services (MPAEADAJ), Equine Therapeutics (Rx) (HLAMAEAC)

Keywords

• Equine drug testing
• Horse racing integrity
• Medication regulation research
• Racehorse safety standards
• Regulatory veterinary education

Headquarters

HQ city

Lexington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Membership/Integrity Partner Contributions: RMTC operates as a non-profit consortium funded by 23 member organizations representing the spectrum of horse racing. Additional funding comes from Integrity Partners including the William M. Backer Foundation, Perry R. Bass II Foundation, Paul & Kathryn Smoke, and Adele Dilschneider.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

The Racing Medication Testing Consortium (RMTC) is a nonprofit consortium that funds and manages scientific research on equine medication and doping, develops the Schedule of Controlled Therapeutic Substances (CTS) with regulatory thresholds and withdrawal guidance for 28 therapeutic medications, operates the RegVet CE continuing education program for regulatory veterinarians, and accredits equine drug testing laboratories through an External Quality Assurance Program. It functions as a coalition of 23 horse racing industry organizations (owners, breeders, trainers, veterinarians, jockeys, regulators, racetracks, racing associations, breed organizations) and proposes Model Rules adopted by the Association of Racing Commissioners International (ARCI) and Horseracing Integrity and Safety Authority (HISA).

Product overview

The Racing Medication and Testing Consortium (RMTC) is a research, education, and advocacy organization—not a software product company. Its core offerings consist of the Schedule of Controlled Therapeutic Substances (CTS) with withdrawal guidance for 28 medications, the RegVet CE continuing education conference, the Laboratory Accreditation Program for equine drug testing labs, Technical Resources (advisories, bulletins, best practices), a Research Program funding studies at universities, and the Racing Industry Veterinary Student Externship Program. These services work together to promote science-based medication regulation and racing integrity.

Differentiator

Problem solved

Functional benefit

Products and services

• Schedule of Controlled Therapeutic Substances (CTS) Regulatory framework listing 28 therapeutic medications with established thresholds and withdrawal guidance, affording horses access to ethical veterinary care while ensuring medications do not impact racing safety or athletic performance. Targeted at state racing commissions, trainers, and attending veterinarians across North America.
• RegVet CE Annual continuing education conference for regulatory and official racetrack veterinarians providing AAVSB RACE-approved training on duties and responsibilities in protecting racehorse health and supporting competition integrity. Delivered as in-person events at major North American racetracks plus a live webinar series with on-demand access.
• Laboratory Accreditation Program Program for accrediting equine drug testing laboratories through the Horseracing Testing Laboratory Committee (HTLC), including the External Quality Assurance Program (EQAP) and Laboratory Code of Standards to ensure consistent and reliable drug testing across racing jurisdictions.
• Technical Resources Comprehensive library of educational materials including advisories, bulletins, best practices guides, downloadable brochures, and webinars/presentations on medication regulations and racing integrity, distributed free via the RMTC website.
• Research Program Funding and management of scientific research on doping threats, medication control strategies, testing methods development, and anti-doping enforcement at academic institutions including Cornell, UC Davis, University of Pennsylvania, University of Florida, Ohio State, and Colorado State; over $3 million invested in 50+ studies since 2003 producing 40+ peer-reviewed publications.
• Racing Industry Veterinary Student Externship Program Program providing veterinary students with racetrack experience through externships with racetrack practitioners and regulatory veterinarians to promote careers in equine veterinary medicine; 25 externships funded by sponsors including AVMA Trust, AAEP Foundation, Breeders' Cup, and HISA in 2025.
• Controlled Therapeutic Substances Monograph Series Collection of monographs providing detailed information on CTS medications, including regulatory thresholds, withdrawal guidance, and the science behind their development, serving as an authoritative reference for regulators, veterinarians, and trainers.

Quantifiable outcome

• Decline in racing-related equine fatalities from 2.00 per 1,000 starts (2009) to 1.04 per 1,000 starts (2025), representing 48% reduction under HISA Racetrack Safety Program
• +5 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

13 partnerships are on record, tiered core and minor.

• AAEP (American Association of Equine Practitioners)coreStrategic or Co-development PartnerMember organization and co-developer of the Controlled Therapeutic Substances schedule. AAEP represents equine veterinarians and provides veterinary expertise for medication regulation recommendations. AAEP is a sponsor of RegVet CE 2026.
• ARCI (Association of Racing Commissioners International)coreStrategic or Co-development PartnerRMTC proposes Model Rules to ARCI, which engages in collective policy formation to promote uniformity in horse racing regulation. ARCI members advocate for adoption of Model Rules at the state level.
• HISA (Horseracing Integrity and Safety Authority)coreStrategic or Co-development PartnerCollaborates with HISA on racetrack safety and anti-doping programs. HISA sponsors the Racing Industry Veterinary Student Externship Program. RegVet CE 2026 includes sessions on HISA Racetrack Safety Program updates.
• HIWU (Horseracing Integrity and Welfare Unit)coreStrategic or Co-development PartnerDrug Free Sport International subsidiary implementing HISA's Anti-Doping and Medication Control Program. HIWU provides anti-doping and medication control regulations and operations updates for RegVet CE participants.
• NTRA (National Thoroughbred Racing Association)coreStrategic or Co-development PartnerMember organization and co-sponsor with RMTC of RegVet CE educational programming. NTRA and RMTC combined resources to develop continuing education content specific to racing regulatory veterinarians.
• William M. Backer FoundationminorOthersIntegrity Partner providing financial support for RMTC's mission to promote safety and integrity in horse racing through research, education, and advocacy.
• Perry R. Bass II FoundationminorOthersIntegrity Partner providing financial support for RMTC's mission to promote safety and integrity in horse racing through research, education, and advocacy.
• EHSLC (European Horseracing Scientific Liaison Committee)minorStrategic or Co-development PartnerIndependent organization with roles comparable to RMTC, conducting research and making recommendations for controlling medication use in European racing. Collaborates with IFHA on international strategies.
• Los Alamitos Race CoursecoreStrategic or Co-development PartnerHost venue for RegVet CE 2026 in-person event on March 9-10, 2026 in Cypress, CA. Provides facility for hands-on wetlab sessions and conference programming.
• AAEP (American Association of Equine Practitioners)coreStrategic or Co-development PartnerProvides on-demand access to RegVet CE 2026 Webinar Series recordings. Educational content approved by AAVSB RACE program for continuing education credit toward veterinary license renewal.
• AVMA TrustminorOthersSponsor of RMTC's 2025 Racing Industry Veterinary Student Externship Program. AVMA PLIT and AVMA LIFE provide funding to support veterinary student externship opportunities.
• Breeders' Cup Ltd.minorOthersSponsor of the Racing Industry Veterinary Student Externship Program, supporting recruitment and training of young veterinarians for careers in horse racing.
• IGSRV (International Group of Specialist Regulatory Veterinarians)minorStrategic or Co-development PartnerInternational organization of regulatory veterinarians. Offers $100 discount on RegVet CE course fees for IGSRV members attending the educational programming.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Racing Analytical Services (Australia): Australian and other national racing laboratories serve as international peers to RMTC's accredited labs through the Horseracing Testing Laboratory Committee. They perform comparable GC/MS and LC/MS drug testing under their own regulatory frameworks, making them functional equivalents to RMTC-accredited facilities.

Direct peers

• European Horseracing Scientific Liaison Committee (EHSLC): EHSLC is RMTC's closest international functional peer — an independent organization conducting research and making recommendations on medication use in European racing, collaborating with IFHA on international strategies. Highly comparable in scope and scientific remit.
• Association of Racing Commissioners International (ARCI): ARCI is the most direct peer — a racing industry standards body that proposes model rules adopted by state racing commissions. RMTC specifically proposes Model Rules to ARCI for collective policy formation, making them co-regulators in the same North American racing integrity ecosystem.
• Horseracing Integrity and Welfare Unit (HIWU): HIWU implements HISA's Anti-Doping and Medication Control Program and is the operational arm closest to RMTC's mission. It relies on RMTC-developed research and provides anti-doping regulations that RegVet CE participants are trained on, making it a tightly-coupled implementation peer.
• American Association of Equine Practitioners (AAEP): AAEP represents equine veterinarians and is a member of RMTC, co-developing the Controlled Therapeutic Substances schedule. It serves as a distribution partner for RegVet CE on-demand content, making it a closely aligned professional society peer in equine veterinary regulation.

Broad incumbents

• Horseracing Integrity and Safety Authority (HISA): HISA is the federally-authorized national regulator of U.S. horse racing safety and anti-doping. It is a broader incumbent that increasingly overlaps with RMTC's standards-setting function, with RMTC's research feeding HISA's program and the Executive Director holding a concurrent HIWU role.
• International Federation of Horseracing Authorities (IFHA): IFHA is the global governing body for horse racing that coordinates anti-doping and medication policy across jurisdictions. It is a broader incumbent that RMTC engages with through EHSLC and HISA, providing international harmonization that parallels RMTC's domestic role.

Others

• National Thoroughbred Racing Association (NTRA): NTRA is a member organization of RMTC and co-sponsor of RegVet CE. While it is a broader industry trade association rather than a direct regulatory peer, it shares leadership and programming with RMTC and represents the Thoroughbred industry's national voice on integrity issues.
• Drug Free Sport International: Parent company of HIWU and a global anti-doping program administrator. While not a racing-specific peer, Drug Free Sport is the operational backbone that delivers the program RMTC's research helps inform — an enabling/adjacent player in the same value chain.

Regional players

• Thoroughbred Racing Protective Bureau (TRPB): TRPB provides investigative and integrity services to North American racing, complementing RMTC's scientific/standards work with law-enforcement-style monitoring. It is a peer in the racing integrity value chain, focused on detecting misconduct rather than setting scientific thresholds.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/RMTCnet
• LinkedInlinkedin.com/company/racing-medication-and-testing-consortium

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Racing Medication Testing Consortium